SGLT-2 inhibitors linked to lower risk of diabetic foot nerve damage

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose ...
MPR

Risk for Foot Disease Modestly Lower With SGLT-2 Inhibitors vs GLP-1 Receptor Agonists in T2DM

Lower risk for foot disease driven by lower risk for neuropathy for new users of SGLT-2 inhibitors versus GLP-1 receptor agonists ...
Medscape

A Step Forward in Diabetic Foot Disease Management

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
MedPage Today

Pemafibrate Takes a Small Step Forward in Diabetic Foot Ulcers After CVD Flop

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Pemafibrate was ...
Verywell Health on MSN

Diabetes side effects and comorbidities

Medically reviewed by Kelly Wood, MD Key Takeaways People with diabetes have a higher risk of cardiovascular diseases like ...
EurekAlert!

Study finds SGLT-2 inhibitors linked to lower risk of diabetic foot nerve damage

A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing ...
HealthDay

Risk for Foot Disease Modestly Lower With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in T2DM

For adults with type 2 diabetes mellitus (T2DM), new users of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) hav ...